-
UWA Research Recognised In Innovator Of Year Awards
07 Nov 2025 04:43 GMT
… Limited, a healthcare technology and drug development company, was Wesfarmers Wellbeing Platinum Award …
-
Korean biotechs to unveil CAR-T, ADC, and NK-cell data at US hematology meeting
07 Nov 2025 03:37 GMT
Korea’s innovative drug development companies are showcasing their blood cancer …
-
Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
06 Nov 2025 21:01 GMT
… to a late-stage clinical drug development company; Denali’s and its collaborators …
-
Denali Therapeutics Announces Board and Executive Leadership Updates
06 Nov 2025 21:00 GMT
… to a late-stage clinical drug development company; the ability of Denali and …
-
5th Annual BioTech Breakthrough Awards Program Honors World’s Most Innovative Life Sciences and Biotechnology Companies
06 Nov 2025 13:00 GMT
… Therapeutics Drug Discovery & Development
Drug Development Company of the Year: Sionna Therapeutics …
-
Algernon Health Announces Private Placement
06 Nov 2025 12:04 GMT
… , a private U.S. based drug development company advancing a chronic cough drug …
-
Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates
05 Nov 2025 07:12 GMT
… biosimilar developer into a new drug development company. In addition, Phase 1 clinical …
-
BullFrog AI Announces Abstract Accepted for Presentation at 2026 ASCO Gastrointestinal Cancers Symposium
04 Nov 2025 13:00 GMT
… ;Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and …
-
Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
03 Nov 2025 13:00 GMT
… (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics … Bio is a clinical-stage drug development company focused on advancing novel therapeutics …
-
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
02 Nov 2025 14:00 GMT
… . (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics … Bio is a clinical-stage drug development company focused on advancing novel therapeutics …